NCT00909740View on ClinicalTrials.gov

A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 22, 2009

Primary Completion Date

October 26, 2011

Study Completion Date

October 26, 2011

Conditions
Solid Cancers
Interventions
DRUG

MEGF0444A

Intravenous escalating dose

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY